-
Je něco špatně v tomto záznamu ?
Changes in innate and adaptive immunity over the first year after the onset of type 1 diabetes
A. Klocperk, L. Petruzelkova, M. Pavlikova, M. Rataj, J. Kayserova, S. Pruhova, S. Kolouskova, J. Sklenarova, Z. Parackova, A. Sediva, Z. Sumnik,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
Grantová podpora
16-32838A
Ministerstvo Zdravotnictví Ceské Republiky
institutional support
University Hospital in Motol
NV16-32838A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Medline Complete (EBSCOhost)
od 2003-06-01 do Před 1 rokem
- MeSH
- adaptivní imunita * MeSH
- B-lymfocyty imunologie MeSH
- beta-buňky metabolismus MeSH
- C-peptid krev MeSH
- diabetes mellitus 1. typu krev imunologie MeSH
- dítě MeSH
- glykovaný hemoglobin metabolismus MeSH
- inzulin krev MeSH
- kohortové studie MeSH
- lidé MeSH
- mladiství MeSH
- počet leukocytů MeSH
- předškolní dítě MeSH
- přirozená imunita * MeSH
- prospektivní studie MeSH
- regulační T-lymfocyty imunologie MeSH
- věk při počátku nemoci MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
AIMS: The development of the immune phenotype in patients with type 1 diabetes (T1D) during the first year following disease onset remains poorly described, and studies analysing the longitudinal development of a complex set of immunological and metabolic parameters are missing. Thus, we aim to provide such complex view in a cohort of 38 children with new onset T1D who were prospectively followed for 1 year. METHODS: All subjects were tested for a set of immunological parameters (complete blood count; serum immunoglobulins; and T, B and dendritic cells), HbA1c and daily insulin dose at baseline and at 6 and 12 months after T1D diagnosis. A mixed meal tolerance test was administered to each of the subjects 12 months after diagnosis, and the C-peptide area under the curve (AUC) was noted and was then tested for association with all immunological parameters. RESULTS: A gradual decrease in leukocytes (adjusted p = 0.0012) was reflected in a significant decrease in neutrophils (adjusted p = 0.0061) over the post-onset period, whereas Tregs (adjusted p = 0.0205) and originally low pDCs (adjusted p < 0.0001) increased. The expression of the receptor for BAFF (BAFFR) on B lymphocytes (adjusted p = 0.0127) markedly increased after onset. No immunological parameters were associated with C-peptide AUC; however, we observed a linear increase in C-peptide AUC with the age of the patients (p < 0.0001). CONCLUSIONS: Our study documents substantial changes in the innate and adaptive immune system over the first year after disease diagnosis but shows no association between immunological parameters and residual beta-cell activity. The age of patients remains the best predictor of C-peptide AUC, whereas the role of the immune system remains unresolved.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025153
- 003
- CZ-PrNML
- 005
- 20201222160114.0
- 007
- ta
- 008
- 201125s2020 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00592-019-01427-1 $2 doi
- 035 __
- $a (PubMed)31570993
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Klocperk, Adam $u Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic. adam.klocperk@fnmotol.cz.
- 245 10
- $a Changes in innate and adaptive immunity over the first year after the onset of type 1 diabetes / $c A. Klocperk, L. Petruzelkova, M. Pavlikova, M. Rataj, J. Kayserova, S. Pruhova, S. Kolouskova, J. Sklenarova, Z. Parackova, A. Sediva, Z. Sumnik,
- 520 9_
- $a AIMS: The development of the immune phenotype in patients with type 1 diabetes (T1D) during the first year following disease onset remains poorly described, and studies analysing the longitudinal development of a complex set of immunological and metabolic parameters are missing. Thus, we aim to provide such complex view in a cohort of 38 children with new onset T1D who were prospectively followed for 1 year. METHODS: All subjects were tested for a set of immunological parameters (complete blood count; serum immunoglobulins; and T, B and dendritic cells), HbA1c and daily insulin dose at baseline and at 6 and 12 months after T1D diagnosis. A mixed meal tolerance test was administered to each of the subjects 12 months after diagnosis, and the C-peptide area under the curve (AUC) was noted and was then tested for association with all immunological parameters. RESULTS: A gradual decrease in leukocytes (adjusted p = 0.0012) was reflected in a significant decrease in neutrophils (adjusted p = 0.0061) over the post-onset period, whereas Tregs (adjusted p = 0.0205) and originally low pDCs (adjusted p < 0.0001) increased. The expression of the receptor for BAFF (BAFFR) on B lymphocytes (adjusted p = 0.0127) markedly increased after onset. No immunological parameters were associated with C-peptide AUC; however, we observed a linear increase in C-peptide AUC with the age of the patients (p < 0.0001). CONCLUSIONS: Our study documents substantial changes in the innate and adaptive immune system over the first year after disease diagnosis but shows no association between immunological parameters and residual beta-cell activity. The age of patients remains the best predictor of C-peptide AUC, whereas the role of the immune system remains unresolved.
- 650 12
- $a adaptivní imunita $7 D056704
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a věk při počátku nemoci $7 D017668
- 650 _2
- $a B-lymfocyty $x imunologie $7 D001402
- 650 _2
- $a C-peptid $x krev $7 D002096
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a diabetes mellitus 1. typu $x krev $x imunologie $7 D003922
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a glykovaný hemoglobin $x metabolismus $7 D006442
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a přirozená imunita $7 D007113
- 650 _2
- $a inzulin $x krev $7 D007328
- 650 _2
- $a beta-buňky $x metabolismus $7 D050417
- 650 _2
- $a počet leukocytů $7 D007958
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a regulační T-lymfocyty $x imunologie $7 D050378
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Petruzelkova, Lenka $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic.
- 700 1_
- $a Pavlikova, Marketa $u Department of Probability and Mathematical Statistics, Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic.
- 700 1_
- $a Rataj, Michal $u Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic.
- 700 1_
- $a Kayserova, Jana $u Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic.
- 700 1_
- $a Pruhova, Stepanka $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic.
- 700 1_
- $a Kolouskova, Stanislava $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic.
- 700 1_
- $a Sklenarova, Jana $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic.
- 700 1_
- $a Parackova, Zuzana $u Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic.
- 700 1_
- $a Sediva, Anna $u Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic.
- 700 1_
- $a Sumnik, Zdenek $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic.
- 773 0_
- $w MED00000037 $t Acta diabetologica $x 1432-5233 $g Roč. 57, č. 3 (2020), s. 297-307
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31570993 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222160110 $b ABA008
- 999 __
- $a ok $b bmc $g 1599298 $s 1115839
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 57 $c 3 $d 297-307 $e 20190930 $i 1432-5233 $m Acta diabetologica $n Acta Diabetol $x MED00000037
- GRA __
- $a 16-32838A $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a institutional support $p University Hospital in Motol
- GRA __
- $a NV16-32838A $p MZ0
- LZP __
- $a Pubmed-20201125